Cargando…
Employing novel animal models in the design of clinically efficacious GPCR ligands()
The headline success of targeting GPCRs in human diseases has masked the fact that many GPCR drug discovery programmes fail. This is despite a substantial increase in our understanding of GPCR pharmacology that has provided an array of ligands that target both orthosteric and allosteric sites as wel...
Autores principales: | Bradley, Sophie J, Riaz, Sajjad A, Tobin, Andrew B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3989050/ https://www.ncbi.nlm.nih.gov/pubmed/24680437 http://dx.doi.org/10.1016/j.ceb.2013.12.002 |
Ejemplares similares
-
Harnessing cyclotides to design and develop novel peptide GPCR ligands
por: Muratspahić, Edin, et al.
Publicado: (2020) -
GPCRdb in 2018: adding GPCR structure models and ligands
por: Pándy-Szekeres, Gáspár, et al.
Publicado: (2018) -
A computational model for GPCR-ligand interaction prediction
por: Karimi, Shiva, et al.
Publicado: (2020) -
Family a GPCR heteromers in animal models
por: González-Maeso, Javier
Publicado: (2014) -
Improved GPCR ligands from nanobody tethering
por: Cheloha, Ross W., et al.
Publicado: (2020)